Products In many countries, kava is currently only available in the form of highly diluted homeopathic medicines. For example, Similasan Kava-Kava tablets contain kava in the homeopathic potencies D12, D15 and D30. This remedy no longer contains kava. Mother tinctures and low potencies up to and including D6 may no longer be sold. Previously distributed … Kava
Products Axitinib was approved in many countries in 2012 in film-coated tablet form (Inlyta). Structure and properties Axitinib (C22H18N4OS, Mr = 386.5 g/mol) is a benzamide and benzindazole derivative. It exists as a white to slightly yellow powder. Effects Axitinib (ATC L01XE17) has antitumor properties. The effects are due to inhibition of VEGFR-1, -2, and … Axitinib
Products The marketing of medicinal products containing dihydroergotamine has been discontinued in many countries (e.g., Dihydergot tablets and nasal spray, Ergotonin, Effortil plus, Old Tonopan, and others). The approval of Dihydergot tablets was cancelled on February 1, 2014, because the benefits no longer outweighed the potential risks, according to drug regulators. Structure and properties Dihydroergotamine … Dihydroergotamine
Products Kratom is not currently approved as a drug or medical device in many countries. From our point of view, kratom should be classified as a narcotic from a purely technical point of view. However, according to information from Swissmedic, it is not legally a narcotic (as of 1/2015). In 2017, however, the ingredients mitragynine … Kratom
Products Biperiden is commercially available as tablets, sustained-release tablets, and a solution for injection (Akineton, Akineton retard). It has been approved in many countries since 1958. Structure and properties Biperiden (C21H29NO, Mr = 311.46 g/mol) is present in drugs as biperidene hydrochloride, a white crystalline powder that is sparingly soluble in water. It is a … Biperides
Products Benfluorex was marketed in many countries as Mediaxal (150 mg, Servier) until 1998. Today, it is no longer on the market. In France and other European countries, it was available as Mediator, among other products. Its approval was not withdrawn in France until 2009, although the risk for cardiotoxic side effects of comparable drugs … Benfluorex
Products Benzbromarone was withdrawn from the market in many countries in 2003 because of its hepatotoxicity. Desuric and other drugs are no longer available. It is still available in other countries. The withdrawal was not without controversy (Jansen, 2004). Structure and properties Benzobromarone (C17H12Br2O3, Mr = 424.1 g/mol) is a derivative of khellin. It exists … Benzbromarone
Products Sulfadiazine is commercially available in combination with silver as silver sulfadiazine cream and gauze (Flammazine, Ialugen plus). This article refers to internal use. See also under silver sulfadiazine. Structure and properties Sulfadiazine (C10H10N4O2S, Mr =250.3 g/mol) exists as in the form of crystals or as a crystalline powder with white, yellowish or light pink … Sulfadiazine
Withdrawal from the market Rhinathiol Promethazine (Sanofi-Aventis Suisse SA, category C) contained a combination of the sedative antihistamine promethazine and the expectorant mucolytic carbocisteine. According to the package insert, the syrup could be taken for both productive cough and irritable cough (1). It was frequently used in children. The drug was withdrawn from the market … Rhinathiol Promethazine
Products Dexmethylphenidate is commercially available in the form of capsules with a modified release of active ingredient (Focalin XR). It was approved in many countries in 2009. Since it does not contain L-threo-methylphenidate, the strengths are correspondingly half less (5 mg, 10 mg, 15 mg, 20 mg) than Ritalin LA (10 mg, 20 mg, 30 … Dexmethylphenidate
Products Excilor is commercially available in many countries as a dosing pen and, since 2012, also as a solution (Doetsch Grether AG). It is a medical device and not a drug registered with Swissmedic. Ingredients The pen contains acetic acid, ethyl lactate, penetration enhancer, film former, preservative, and water. Effects Excilor penetrates the nail and … Excilor
Products and withdrawal from the market Sibutramine was approved in 1999 and was commercially available in many countries in 10- and 15-mg capsule form (Reductil, Abbott AG). On March 29, 2010, Abbott AG, in consultation with Swissmedic, informed the public that the marketing authorization had been suspended. Since then, sibutramine may no longer be prescribed … Sibutramine
